שווי חברה לרווח נקי Rafael Holdings Corp (RFL)

This visual snapshot of Rafael Holdings, Inc. (RFL) price action demonstrates the performance of a company profiting from real estate holdings and medical developments, where the current ratio is -1.60. The holding company is currently focused on internal capital to support its startups, having temporarily suspended external merger deals. Growth is driven by rental income from Newark offices and the promotion of new oncology drugs.
פילוחים אנליטיים של חברת Rafael Holdings, Inc.

Effective management of biopharmaceutical assets and real estate at Rafael Holdings, Inc. (RFL) establishes the foundation for the company's business valuation. By analyzing the P/E ratio of Rafael Holdings, Inc. (RFL), an investor sees the result of dividing the market share price by net income, which determines the payback period for investments and allows for the separation of speculative bubbles from the fundamental stability of the investment holding.